A novel N-myristylated synthetic octapeptide inhibits protein kinase C activity and partially reverses murine fibrosarcoma cell resistance to Adriamycin

C. O'brian,N. Ward,R. Liskamp,D. B. Bont,L. Earnest,J. H. Boom,D. Fan
DOI: https://doi.org/10.1007/BF00175084
1991-05-01
Investigational New Drugs
Abstract:
What problem does this paper attempt to address?